NCT02262949View on ClinicalTrials.gov

A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2016

Conditions
Peripheral Artery Disease
Interventions
DEVICE

LifeStent Vascular Stent

PTA followed by implantation of the LifeStent Vascular Stent (stent length 250 mm) in the SFA or popliteal artery.

Trial Locations (4)

13347

Gemeinschaftspraxis für Radiologie, Berlin

76646

Fürst Stirum Klinik Bruchsal, Bruchsal

79189

University Heart Centre Freiburg, Bad Krozingen

83022

RoMed Klinikum Rosenheim, Rosenheim

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02262949 - A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System | Biotech Hunter | Biotech Hunter